Sander I, Kespohl S, Zahradnik E, Göcke P, Hosbach I, Herrmann BL, Brüning T, Raulf M (2022): Quantitative measurement of IgG to SARS‐CoV‐2 antigens using monoclonal antibody‐based enzyme‐linked immunosorbent assays. Clin Transl Immunology. 2022; 11(2): e1369. Published online 2022 Jan 30. doi: 10.1002/cti2.1369

Herrmann, B.L. The prevalence rate of anti-SARS-CoV-2-IgG is 1.2% – Screening in asymptomatic outpatients in Germany (Northrhine-Westfalia). MMW – Fortschritte der Medizin 162, 44–46 (2020)

Herrmann BL, Stalla GK, Laubner, K, Bidlingmaier M, Fuehrer-Sakel D (2017) Obstructive Sleep Apnea Syndrome Is Less Frequent in Patients With Well-Controlled Acromegaly Treated With Somatostatin Analogues, Pegvisomant or in Combination . Journal Endocrinology and Metabolism, Volume 7, Number 5, October, 141-145

Herrmann BL, Kasser C, Keuthage W, Huptas M, Dette H, Klute A (2013) Comparison of insulin aspart vs. regular human insulin with or without insulin detemir concerning adipozytokines and metabolic effects in patients with type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes.Apr;121(4):210-3.

Bertsch T, Aschenneller C, Bewarder N, Beyrau R, Herrmann BL, Jansen E, Klapdor R, Klemm M, Meissner J, Pfeiffer S, Schauer I, Stratmann MM, Theimer C, van de Loo HM, Wildbredt DA, Wolff C, Wollenberg P (2013) European proficiency study with control serum for the tumor marker CA 19-9 measured on different test systems. Clin Lab. 59(1-2):185-92.

Ball A, Wolf CC, Ocklenburg S, Herrmann BL, Pinnow M, Brüne M, Wolf OT, Güntürkün O (2013) Variability in ratings of trustworthiness across the menstrual cycle. Biol Psychol. Apr;93(1):52-7. doi: 10.1016/j.biopsycho.2013.01.005. Epub 2013 Jan 23.

Berg C, Petersenn S, Lahner H, Herrmann BL, Buchfelder M, Droste M, Stalla GK, Strasburger CJ, Roggenbuck U, Lehmann N, Moebus S, Jöckel KH, Möhlenkamp S, Erbel R, Saller B, Mann K; Investigative Group of the Heinz Nixdorf Recall Study and the German Pegvisomant Observational Study Board and Investigators (2010) Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control. J Clin Endocrinol Metab. Aug;95(8):3648-56. doi: 10.1210/jc.2009-2570. Epub 2010 May 12.

Herrmann BL, Schmid KW, Bockisch A, Kemen M, Mann K (2009) Calcitonin screening and pentagastrin testing: predictive value for diagnosis medullary carcinoma in nodular thyroid disease. Eur J Endocrinol Jun;162(6):1141-5.

Herrmann BL, Mortsch F, Berg C, Weischer T, Mohr C, Mann K (2009) Acromegaly: A cross sectional analysis of the oral and maxillofacial pathologies. Exp Clin Endocrinol Diabetes 2010 Jul 23

Herrmann BL Severing M, Schmermund A, Berg C, Budde Th, Erbel R, Mann K (2009) Impact of Disease Duration on Coronary Calcification in Patients with Acromegaly. Exp Clin Endocrinol Diabetes Sep;117(8):417-22

Berg, C, Oeffner A, Schumm-Draeger PM, Badorrek F, Brabant G, Gerbert B, Bornstein S, Zimmermann A, Weber M, Broecker-Preuss M, Mann K, Herrmann BL (2009) Prevalence of Anterior Pituitary Dysfunction in Patients following Traumatic Brain Injury in a German multi-centre Screening Program. Exp Clin Endocrinol Diabetes, Aug;95(8):3648-56

Berg C, Wessendorf TE, Mortsch F, Forsting M, Teschler H, Weischer T, Mann K, Saller B, Herrmann BL (2009) Influence of Disease Control with Pegvisomant on Sleep Apnoea and Tongue Volume in Patients with Active Acromegaly. Eur J Endocrinol 2009 Dec;161(6):829-35.

Buchfelder M, Weigel D, Droste M, Mann K, Saller B, Brübach K, Stalla GK, Bidlingmaier M, Strasburger CJ; Investigators of German Pegvisomant Observational Study with Herrmann BL. (2009) Pituitary tumor size in acromegaly during pegvisomant treatment: experience from MR re-evaluations of the German Pegvisomant Observational Study. Eur J Endocrinol. Jul;161(1):27-35.

Petersenn S, Buchfelder M, Gerbert B, Franz H, Quabbe HJ, Schulte HM, Grussendorf M, Reincke M; Participants of the German Acromegaly Register with Herrmann BL. (2009) Age and sex as predictors of biochemical activity in acromegaly: analysis of 1485 patients from the German Acromegaly Register. Clin Endocrinol (Oxf). Sep;71(3):400-5.

Buchfelder M, Schlaffer S, Droste M, Mann K, Saller B, Brübach K, Stalla GK, Strasburger CJ; Participants of the German Acromegaly Register with Herrmann BL. (2009) The German Acrostudy: past and present. Eur J Endocrinol. 2009 Nov;161 Suppl 1:S3-S10.

Petersenn S, Buchfelder M, Reincke M, Strasburger CM, Franz H, Lohmann R, Quabbe HJ, Plöckinger U; Participants of the German Acromegaly Register with Herrmann BL. (2008) Results of surgical and somatostatin analog therapies and their combination in acromegaly: a retrospective analysis of the German Acromegaly Register. Eur J Endocrinol. Nov;159(5):525-32.

Brauck K, Galbán CJ, Maderwald S, Herrmann BL, Ladd ME. (2007) Changes in calf muscle elasticity in hypogonadal males before and after testosterone substitution as monitored by magnetic resonance elastography. Eur J Endocrinol. 156(6):673-8.

Herrmann BL, Rehder J, Kahlke S, Wiedemayer H, Doerfler A, Ischebeck W, Laumer R, Forsting M, Stolke D, Mann K (2006) Hypopituitarism following severe traumatic brain injury. Exp Clin Endocrinol Diabetes. 114: 316-321

Schneider HJ, Herrmann BL, Schneider M, Sievers C, Schaaf L, Stalla GK. (2006) Discrepant results in the diagnosis of GH deficiency with the insulin-tolerance test and the GHRH plus arginine test in patients with traumatic brain injury. Eur J Endocrinol. 155(4):553-7.

Hahn S, Tan S, Elsenbruch S, Quadbeck B, Herrmann BL, Mann K, Janssen OE. (2005) Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia. Horm Metab Res 37(7):438-444

Hahn S, Fingerhut A, Khomtsiv U, Khomtsiv L, Tan S, Quadbeck B, Herrmann BL, Knebel B, Muller-Wieland D, Mann K, Janssen OE. (2005) The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 62(5):573-579

Ajaj W, Goyen M, Herrmann B, Massing S, Goehde S, Lauenstein T, Ruehm SG (2005) Measuring tongue volumes and visualizing the chewing and swallowing process using real-time TrueFISP imaging-initial clinical experience in healthy volunteers and patients with acromegaly. Eur Radiol 15(5):913-918

Herrmann BL, Saller B, Stratmann M, Berg C, Mann K, Janssen OE (2005) Effects of recombinant human growth hormone on adiponectin levels in patients with metabolic syndrome. Horm Metabol Res 37(1): 49-52

Herrmann BL, Janssen OE, Hahn S, Broecker-Preuss M, Mann K (2005) Effects of Estrogen Replacement Therapy on Bone and Glucose Metabolism in a Male with Congenital Aromatase Deficiency. Horm Metabol Res 37(3): 178-183

Herrmann BL, Wessendorf TE, Ajaj W, Kahlke S, Teschler H, Mann K (2004) Effects of octreotide on sleep apnoea and tongue volume (MRI) in patients with acromegaly. Eur J Endocrinol Sep;151(3):309-15

Herrmann BL, Baumann H, Janssen OE, Goerges R, Schmid KW, Mann K (2004) Impact of disease activity on thyroid diseases in patients with acromegaly: basal evaluation and follow up. Exp Clin Endocrinol Diabetes. 112: 225-230.

Herrmann BL, Berg C, Vogel E, Nowak T, Renzing-Koehler K, Mann K, Saller B (2004) Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with meatbolic syndrome. Horm Metab Res. 36(1): 1-8.

Herrmann BL, Brandt-Mainz K, Saller B, Bruch C, Wienecke H, Kügler H, Ferdin S, Hahn S, Erbel R, Bockisch A, Mann K (2003) Myocardial perfusion abnormalities in patients with active acromegaly. Horm Metab Res. 35(3):183-188.

Herrmann BL, Saller B, Janssen OE, Gocke P, Bockisch A, Sperling H, Mann K, Broecker M (2002) Impact of Estrogen Replacement Therapy in a Male with Congenital Aromatase Deficiency Caused by a Novel Mutation in the CYP19 Gene. J Clin Endocrinol Metab. 87:5476-5484.

Herrmann BL, Bruch C, Saller B, Bartel T, Ferdin S, Erbel R, Mann K (2002) Acromegaly: evidence for a direct relation between disease activity and cardiac dysfunction in patients without ventricular hypertrophy. Clin Endocrinol (Oxf). 56:595-602.

Bruch C, Herrmann B, Schmermund A, Bartel T, Mann K, Erbel R (2002) Impact of disease activity on left ventricular performance in patients with acromegaly. Am Heart J. 144:538-543.

Herrmann BL, Bruch C, Saller B, Ferdin S, Dagres N, Ose C, Erbel R, Mann K (2001) Occurrence of ventricular late potentials in patients with active acromegaly. Clin Endocrinol (Oxf). 55:201-207.

Naber C*, Hermann BL*, Vietzke D, Altmann C, Haude M, Mann K, Rosskopf D, Siffert W (2000) [*These authors contributed equally to this project.] Enhanced epinephrine-induced platelet aggregation in individuals carrying the G protein beta3 subunit 825T allele. FEBS Lett. 484:199-201.

Schafers RF, Nurnberger J, Herrmann B, Wenzel RR, Philipp T, Michel MC (1999) Adrenoceptors mediating the cardiovascular and metabolic effects of alpha-methylnoradrenaline in humans. J Pharmacol Exp Ther. 289:918-925.

Herrmann BL, Schatz H, Pfeiffer A (1998) [Continuous blood glucose monitoring: the acute effect of acarbose on blood glucose variations]. Med Klin. 93:651-655.

Herrmann BL (2017) Diabetesmanagement: Strategien für die Insulintherapie. Ärztliches Journal Reise & Medizin 1/2017 64-65

Herrmann BL (2015) Schilddrüse und Psyche: Unter- oder Überfunktion? Deutsche Hebammenzeitschrift 1/215: 65-68.

Herrmann BL (2014) Die Osteoporose des Mannes.– Chirurgische Allgemeine, Heft 10, Oktober 2014, S. 617-619 – ISDN 1615-5378

Herrmann BL, (2014) Der Blick auf die kardiovaskuläre Sicherheit, Der niedergelassene Arzt, 7/21.07.2014

Herrmann BL, (2013) Akromegalie – Frühe Diagnose verlängert das Leben, Der Allgemeinarzt, 35 (8) Seite 38-40

Herrmann BL, Strasburger CJ (2004) Growth hormone receptor antagonist Pegvisomant. Dtsch Med Wochenschr 129(44): 2356-2358

Herrmann BL, Erbel R, Mann K (2004) Kardiovaskuläre Effekte oraler Antidiabetika. Herz Aug;29(5):510-8

Herrmann BL, Erbel, R, Janssen OE, Mann K (2004) Kardiovaskuläre Effekte oraler Antidiabetika, Herz 29, No.5, 510-518

Herrmann BL, Mann K, Janssen OE (2004) Diagnostics of growth hormone deficiency and excess (acromegaly). L Lab Med 28(2): 127-134.

Janssen OE, Hahn S, Elsenbruch S, Quadbeck B, Herrmann BL, Mann K, Gärtner R (2004) Metformin zur Behandlung des Polycystischen Ovarialsyndroms. Diabetes & Stoffwechsel: 105-112.

Herrmann BL, Mann K (2003) Das hypophysäre Koma. Internist 44(10): 1253-1259.

Herrmann BL (2020) Wachstumshormon; in Enzyklopädie der Schlafmedizin, Springer Verlag

Herrmann BL (2020) Hypophyse und Hypothalamus-Hypophysen-Nebennierenachse. Enzyklopädie der Schlafmedizin, 3. Auflage. Springer Verlag

Hermann BL (2017) Wachstumshormon und Hypophysenfunktion. Enzyklopädie des Schlafes, 2. Auflage. Springer Verlag

Hadji P, Rabe T, Herrmann BL (2013) Knochendichtemessung – Seminar Gynäkologische Endokrinologie. S. 506-511 – Band 2 ISBN 078-3-00-042948-4

Herrmann BL (2011) Thiamine and Benfotiamine: Underrated Therapeutic Potential in Cardiovascular Disorders and Diabetes? P. 34-43 – Thieme-Verlag ISBN 978-3-13-162451-2

Hermann BL (2005) Wachstumshormon und Hypophysenfunktion. Enzyklopädie des Schlafes. Springer Verlag

Herrmann BL, Mann K (2004) Hypophyseninsuffizienz, Manual endokrinologischer Funktionstests (2.Auflage), S. 1-22, ISBN 3-9810221-0-6

Herrmann BL, Erbel R (2004) Koronare Herzerkrankung: Klinik und Diagnostik. In: Diabetes und Herz von Meinertz T, Rösen P, Schöming A, Tschöpe D, Ziegler D. Steinkopff Verlag, Darmstadt

Herrmann BL, Mann K (2004) Hypophyseninsuffizienz, Manual endokrinologischer Funktionstests, S. 1-22, Art.-Nr. 0918883

Herrmann BL, Baumann H, Janssen OE, Goerges R, Schmid KW, Mann K (2004) Knoten und Strumaprävalenz bei Patienten mit Akromegalie – Einfluss der Behandlung durch Senkung der GH und IGF-I-Spiegel. In Schilddrüse 2003; S.170-172. Walter de Gruyter GmbH Verlag, Berlin

Herrmann BL (2001): Metabolisches Syndrom – Ein Schulungsprogramm. Diabetesprofi (S. 44-48). Kirchheim Verlag.

Kordish I, Herrmann BL, Lahner H, Schroeder T, Janssen OE, Mann K (2003) Rhabdomyolysis, hyponatremia and fever in a patients with Schmidt`s syndrome. Dtsch Med Wochenschr. 128:1649-1652.

Herrmann BL, Mitchell A, Saller B, Stolke D, Forsting M, Frilling A, Mann K (2001) [Transsphenoidal hypophysectomy of a patient with an ACTH-producing pituitary adenoma and an „empty sella“ after pretreatment with etomidate]. Dtsch Med Wochenschr. 126:232-234.

Herrmann BL, Saller B, Kiess W, Morgenroth K, Drochner K, Schroder T, Mann K (2000) Primary malignant fibrous histiocytoma of the lung: IGF-II producing tumor induces fasting hypoglycemia. Exp Clin Endocrinol Diabetes. 108:515-518.

Herrmann BL, Saller B, Sauer J, Brockmeyer N, Mann K (1999) [26-year-old patient with cutaneous leishmaniasis and an initial diabetes mellitus manifestation]. Internist (Berl). 40:561-564.

2020

Hypophyse und Hypothalamus-Hypophysen-Nebennierenachse
(Prof. Dr. Herrmann 01|2020)

2019

Aktuelles von der Norddeutschen Hormonkonferenz 22.-23. Februar 2019
(Prof. Dr. Herrmann 03|2019)

2017

Aktuelles von der Nationalen Schilddrüsenkonferenz Oktober 2017 in Heidelberg
(Prof. Dr. Herrmann 10|2017)

Aktuelles vom Deutschen Diabetes-Kongress Mai 2017 in Hamburg
(Prof. Dr. Herrmann 5|2017)

2016

Diabetesmanagement: Strategien für die Insulintherapie
(Prof. Dr. Herrmann in ärztliches journal reise & medizin 1|2017)

2015

Neuigkeiten zur Akromegalie
(Vortrag von Prof. Dr. Herrmann, Bochum Jahrestagung der Deutschen Gesellschaft für Innere Medizin am 18.04.2015, www. endo-bochum.de)

Neuigkeiten zur Struma nodosa / zystica
(American Endocrine Society, San Diego März 2015)

Update Akromegalie DGIM 2015
Endokrinologie /// Diabetologie /// Innere Medizin
(eigene Publikation)